These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21412607)

  • 1. Assessment measures in systemic lupus erythematosus.
    Freire EA; Souto LM; Ciconelli RM
    Rev Bras Reumatol; 2011; 51(1):70-80. PubMed ID: 21412607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune thyroid disease in patients with rheumatic diseases.
    Robazzi TC; Adan LF
    Rev Bras Reumatol; 2012; 52(3):417-30. PubMed ID: 22641595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects.
    Yee CS; McElhone K; Teh LS; Gordon C
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):457-67. PubMed ID: 19591777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How does one assess and monitor patients with systemic lupus erythematosus in daily clinical practice?
    Haq I; Isenberg DA
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):181-94. PubMed ID: 12041948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosus.
    Stoll T; Gordon C; Seifert B; Richardson K; Malik J; Bacon PA; Isenberg DA
    J Rheumatol; 1997 Aug; 24(8):1608-14. PubMed ID: 9263159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
    Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
    Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?
    Jolly M
    J Rheumatol; 2005 Sep; 32(9):1706-8. PubMed ID: 16142864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
    Griffiths B; Mosca M; Gordon C
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between alexithymia and psychological factors in systemic lupus erythematosus.
    Barbosa F; Mota C; Patrício P; Alcântara C; Ferreira C; Barbosa A
    Compr Psychiatry; 2011; 52(6):754-62. PubMed ID: 21193176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life in systemic lupus erythematosus.
    Panopalis P; Clarke AE
    Clin Dev Immunol; 2006; 13(2-4):321-4. PubMed ID: 17162373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Social support and health in patients with systemic lupus erythematosus: a literature review.
    Mazzoni D; Cicognani E
    Lupus; 2011 Oct; 20(11):1117-25. PubMed ID: 21828159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
    Wolfe F; Michaud K; Li T; Katz RS
    J Rheumatol; 2010 Feb; 37(2):296-304. PubMed ID: 20032098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease.
    Vu TV; Escalante A
    J Rheumatol; 1999 Dec; 26(12):2595-601. PubMed ID: 10606368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between health-related quality of life and SLE activity and damage in children over time.
    Moorthy LN; Peterson MG; Hassett AL; Baratelli M; Chalom EC; Hashkes PJ; Hong S; Reiff A; Lehman TJ
    Lupus; 2009 Jun; 18(7):622-9. PubMed ID: 19433463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
    J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic lupus erythematosus and allergy: an integrative review of the literature].
    de Lucena GR; Gonçalves RT; Braz AS; Freire EA
    Acta Reumatol Port; 2013; 38(3):162-70. PubMed ID: 24149012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.